Marc Goodman
Stock Analyst at Leerink Partners
(4.86)
# 360
Out of 4,534 analysts
843
Total ratings
56.2%
Success rate
18.7%
Average return
Main Sectors:
Stocks Rated by Marc Goodman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NGEN NervGen Pharma | Initiated Coverage: Buy | $10 | $1.73 | +478.03% | 1 | Jul 13, 2026 | |
| RAPP Rapport Therapeutics | Initiated Coverage: Buy | $52 | $40.21 | +29.32% | 1 | Jun 24, 2026 | |
| STOK Stoke Therapeutics | Maintained: Buy | n/a | $27.68 | - | 11 | Jun 2, 2026 | |
| SPTX Seaport Therapeutics | Initiated Coverage: Buy | $35 | $20.55 | +70.32% | 1 | May 27, 2026 | |
| ACIU AC Immune | Maintained: Buy | n/a | $2.25 | - | 38 | Apr 7, 2026 | |
| ALKS Alkermes | Maintained: Hold | n/a | $51.72 | - | 45 | Mar 31, 2026 | |
| SGP SpyGlass Pharma | Initiated Coverage: Buy | $42 | $20.02 | +109.79% | 1 | Mar 3, 2026 | |
| MANE Veradermics | Initiated Coverage: Buy | $75 | $106.04 | -29.27% | 1 | Mar 2, 2026 | |
| NMRA Neumora Therapeutics | Initiated Coverage: Buy | $8 | $1.63 | +390.80% | 1 | Jan 11, 2026 | |
| BHVN Biohaven | Maintained: Buy | $50 → $15 | $14.86 | +0.94% | 26 | Dec 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $35.99 | -16.64% | 1 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $2.31 | +116.92% | 1 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 | $152.84 | -44.39% | 13 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $11.73 | +326.26% | 13 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $30 | $25.09 | +19.57% | 46 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $199.95 | - | 58 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $215 | $243.47 | -11.69% | 54 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $66.04 | - | 31 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $221.64 | - | 52 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.55 | - | 42 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $20 | $17.45 | +14.61% | 34 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $30.90 | +10.03% | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $173.00 | - | 48 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $4.00 | +400.00% | 4 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $22.90 | +74.67% | 16 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $1.70 | +488.24% | 40 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $42.80 | -53.27% | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $4.96 | +625.81% | 11 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.00 | n/a | 33 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1 | $0.022 | n/a | 9 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $248.82 | n/a | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $12.22 | n/a | 17 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $1.77 | n/a | 1 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $74.38 | n/a | 10 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $70 | $0.7045 | n/a | 12 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.16 | n/a | 2 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $52.25 | n/a | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $130.26 | n/a | 1 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $34.84 | n/a | 1 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $219.70 | n/a | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $480.50 | n/a | 2 | Mar 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $473 | $672.15 | n/a | 1 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $72 → $57 | $60.16 | n/a | 17 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 → $54 | $16.99 | n/a | 8 | Mar 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $24.75 | n/a | 15 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $34 → $20 | $31.00 | n/a | 26 | Dec 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $124.40 | n/a | 16 | Oct 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $95 | $253.38 | n/a | 14 | Oct 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $98 | $10.59 | n/a | 8 | Oct 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $85 | $1,146.90 | n/a | 12 | Jul 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $28 → $12 | $17.50 | n/a | 8 | Nov 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $118 | $133.21 | n/a | 3 | Nov 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $8 | $3.85 | n/a | 3 | Jun 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $6.61 | n/a | 24 | Mar 21, 2016 |
NervGen Pharma
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $1.73
Upside: +478.03%
Rapport Therapeutics
Jun 24, 2026
Initiated Coverage: Buy
Price Target: $52
Current: $40.21
Upside: +29.32%
Stoke Therapeutics
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $27.68
Upside: -
Seaport Therapeutics
May 27, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $20.55
Upside: +70.32%
AC Immune
Apr 7, 2026
Maintained: Buy
Price Target: n/a
Current: $2.25
Upside: -
Alkermes
Mar 31, 2026
Maintained: Hold
Price Target: n/a
Current: $51.72
Upside: -
SpyGlass Pharma
Mar 3, 2026
Initiated Coverage: Buy
Price Target: $42
Current: $20.02
Upside: +109.79%
Veradermics
Mar 2, 2026
Initiated Coverage: Buy
Price Target: $75
Current: $106.04
Upside: -29.27%
Neumora Therapeutics
Jan 11, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $1.63
Upside: +390.80%
Biohaven
Dec 25, 2025
Maintained: Buy
Price Target: $50 → $15
Current: $14.86
Upside: +0.94%
Nov 21, 2025
Initiated Coverage: Buy
Price Target: $30
Current: $35.99
Upside: -16.64%
Nov 17, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $2.31
Upside: +116.92%
Oct 15, 2025
Reiterated: Buy
Price Target: $85
Current: $152.84
Upside: -44.39%
Oct 9, 2025
Reiterated: Buy
Price Target: $50
Current: $11.73
Upside: +326.26%
Oct 7, 2025
Maintained: Buy
Price Target: $32 → $30
Current: $25.09
Upside: +19.57%
Oct 7, 2025
Maintained: Buy
Price Target: n/a
Current: $199.95
Upside: -
Oct 7, 2025
Maintained: Buy
Price Target: $215
Current: $243.47
Upside: -11.69%
Oct 7, 2025
Maintained: Buy
Price Target: n/a
Current: $66.04
Upside: -
Oct 7, 2025
Maintained: Buy
Price Target: n/a
Current: $221.64
Upside: -
Oct 7, 2025
Maintained: Buy
Price Target: n/a
Current: $5.55
Upside: -
Oct 7, 2025
Maintained: Buy
Price Target: $10 → $20
Current: $17.45
Upside: +14.61%
Oct 6, 2025
Initiated Coverage: Buy
Price Target: $34
Current: $30.90
Upside: +10.03%
Sep 23, 2025
Maintained: Buy
Price Target: n/a
Current: $173.00
Upside: -
Sep 16, 2025
Reiterated: Buy
Price Target: $20
Current: $4.00
Upside: +400.00%
Aug 13, 2025
Maintained: Buy
Price Target: $40
Current: $22.90
Upside: +74.67%
Aug 12, 2025
Maintained: Buy
Price Target: $10
Current: $1.70
Upside: +488.24%
Aug 1, 2025
Reiterated: Buy
Price Target: $20
Current: $42.80
Upside: -53.27%
Aug 1, 2025
Maintained: Buy
Price Target: $36
Current: $4.96
Upside: +625.81%
May 13, 2025
Maintained: Hold
Price Target: n/a
Current: $5.00
Upside: n/a
Mar 26, 2025
Downgraded: Hold
Price Target: $1
Current: $0.022
Upside: n/a
Jan 13, 2025
Maintained: Buy
Price Target: n/a
Current: $248.82
Upside: n/a
May 12, 2023
Maintained: Buy
Price Target: $4
Current: $12.22
Upside: n/a
Jan 24, 2023
Initiated Coverage: Buy
Price Target: $24
Current: $1.77
Upside: n/a
Jul 11, 2022
Maintained: Hold
Price Target: $20
Current: $74.38
Upside: n/a
Jul 11, 2022
Maintained: Hold
Price Target: $70
Current: $0.7045
Upside: n/a
Jun 27, 2022
Maintained: Hold
Price Target: n/a
Current: $4.16
Upside: n/a
May 3, 2022
Maintained: Buy
Price Target: n/a
Current: $52.25
Upside: n/a
May 13, 2021
Maintained: Buy
Price Target: $25
Current: $130.26
Upside: n/a
May 4, 2021
Reiterated: Buy
Price Target: n/a
Current: $34.84
Upside: n/a
Apr 5, 2021
Maintained: Buy
Price Target: $31
Current: $219.70
Upside: n/a
Mar 19, 2019
Downgraded: Hold
Price Target: n/a
Current: $480.50
Upside: n/a
Nov 12, 2018
Initiated Coverage: Buy
Price Target: $473
Current: $672.15
Upside: n/a
May 21, 2018
Downgraded: Hold
Price Target: $72 → $57
Current: $60.16
Upside: n/a
Mar 1, 2018
Reiterated: Buy
Price Target: $46 → $54
Current: $16.99
Upside: n/a
Jan 31, 2018
Maintained: Buy
Price Target: $42
Current: $24.75
Upside: n/a
Dec 18, 2017
Maintained: Hold
Price Target: $34 → $20
Current: $31.00
Upside: n/a
Oct 30, 2017
Maintained: Buy
Price Target: $67
Current: $124.40
Upside: n/a
Oct 13, 2017
Maintained: Hold
Price Target: $95
Current: $253.38
Upside: n/a
Oct 5, 2017
Reiterated: Buy
Price Target: $110 → $98
Current: $10.59
Upside: n/a
Jul 26, 2017
Maintained: Hold
Price Target: $85
Current: $1,146.90
Upside: n/a
Nov 10, 2016
Reiterated: Sell
Price Target: $28 → $12
Current: $17.50
Upside: n/a
Nov 2, 2016
Maintained: Buy
Price Target: $118
Current: $133.21
Upside: n/a
Jun 14, 2016
Maintained: Sell
Price Target: $8
Current: $3.85
Upside: n/a
Mar 21, 2016
Rated: Buy
Price Target: n/a
Current: $6.61
Upside: n/a